Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
批准号:
8444652
负责人:
Stephen D Hursting
金额:
$28.95万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-08-28
关键词:
AdultBiochemicalCaloric RestrictionCell Cycle ProteinsCellsCyclin D1DevelopmentDietEpidermal Growth Factor ReceptorEpidermisEpithelialFamilyFutureGene ExpressionGeneticGrowthGrowth FactorHealthHumanInsulin-Like Growth Factor ILeadLinkLiverMalignant NeoplasmsModelingMolecularMusObesityPathway interactionsPhorbol EstersPhosphorylationPlayPrevalencePrevention strategyPreventivePropertyRegulationRelative (related person)Risk FactorsRoleSalineSignal PathwaySignal TransductionSirolimusSkinSkin NeoplasmsStagingStem cellsTestingTissuesTransgenic MiceTumor PromotionWild Type Mousebasecancer preventioncancer stem cellcancer typecarcinogenesisenergy balancefeedinghuman FRAP1 proteininhibitor/antagonistinsightkeratinocytekinase inhibitormTOR Inhibitormicrobial alkaline proteinase inhibitorpreventreceptorresearch studysoundtranscription factortranslational studytumorigenesis
中文摘要
描述(由申请人提供):卡路里限制(CR)预防成人肥胖症并抑制多种物种的实验性致癌作用。不幸的是,这些CR效应背后的机制还知之甚少。鉴于肥胖发病率的上升,肥胖是许多类型癌症的既定危险因素,迫切需要对CR的影响进行机械性的洞察,以开发新的癌症预防策略。我们最近使用A-ZIP/F1和Akt转基因小鼠的研究表明,Akt和mTOR信号在小鼠皮肤上皮癌发生中起着重要作用。此外,我们已经证明:i)CR降低Akt和mTOR的活性,包括减少包括表皮在内的几个组织中IGF-1受体(IGF-1R)和表皮生长因子(EGF)-R的磷酸化;以及ii)肝脏特异性IGF-1缺陷(LID,导致循环中IGF-1水平降低)通过抑制皮肤肿瘤的促进作用以及通过IGF-1R/EGFR和随后的下游信号通路(包括Akt和mTOR)来模拟CR。此外,我们还发现CR降低了细胞周期蛋白D1,增加了表皮中p27的水平。这些发现表明,CR通过IGF-1R和EGF-R减少信号,通过多个信号通路(包括Akt和mTOR)减少下游信号,最终通过调节细胞周期调节蛋白导致细胞增殖减少。我们将具体研究Akt和mTOR通路在CR的这些效应中的重要性。我们建议使用上皮癌形成的两阶段皮肤模型,结合饮食、遗传和药理学方法来验证这一假说。其具体目的是:1)确定饮食能量平衡操作对佛波酯(TPA)诱导的野生型和肝脏IGF-1缺陷小鼠皮肤肿瘤促进作用的影响;2)检测饮食能量平衡操作引起的细胞信号通路和表皮基因表达的变化;3)研究CR促进皮肤肿瘤作用的机制;4)研究雷帕霉素(mTOR选择性抑制剂)、API-2(选择性Akt抑制剂)和NVP-AE451(IGF-1受体选择性抑制剂)对随机饲养或CR小鼠皮肤肿瘤的预防作用。在上皮癌变中,CR的抗癌作用与IGF-1R/Akt/mTOR通路之间的因果联系的成功建立,将为翻译研究提供可靠的基础,以确定以该通路为靶点是否为预防人类上皮癌的策略。
英文摘要
DESCRIPTION (provided by applicant): Calorie restriction (CR) prevents adult-onset obesity and suppresses experimental carcinogenesis in multiple species. Unfortunately, the mechanisms underlying these CR effects are poorly understood. Given the rising prevalence of obesity, an established risk factor for many types of cancer, mechanistic insights into the effects of CR are urgently needed to develop new cancer prevention strategies. Our recent studies using A-ZIP/F1 and Akt transgenic mice have demonstrated an important role for Akt and mTOR signaling in epithelial carcinogenesis in mouse skin. Furthermore, we have shown that i) CR decreases activity of Akt and mTOR, including reduced phosphorylation of the IGF-1 receptor (IGF-1R) and epidermal growth factor (EGF)-R, in several tissues including the epidermis; and ii) liver-specific IGF-1 deficiency (LID, resulting in reduced circulating IGF-1 levels) mimics CR by inhibiting skin tumor promotion and signaling through the IGF-1R/EGFR and subsequent downstream signaling pathways, including Akt and mTOR in mice. Furthermore, we have found that CR reduces cyclin D1 and increases p27 levels in epidermis. These findings suggest the hypothesis that CR reduces signaling through the IGF-1R and EGF-R, decreasing downstream signaling through multiple signaling pathways (including Akt and mTOR), ultimately leading to decreased proliferation through modulation of cell cycle regulatory proteins. We will specifically examine the importance of the Akt and mTOR pathways in these effects of CR. We propose to use the well-characterized two-stage skin model of epithelial carcinogenesis, in combination with dietary, genetic, and pharmacologic approaches, to test this hypothesis. The specific aims are to The specific aims are to: 1) Determine the impact of manipulation of dietary energy balance on phorbol ester (TPA)-induced skin tumor promotion in wild-type and liver IGF-1-deficient mice; 2) Examine cell signaling pathways and alterations in gene expression in epidermis resulting from dietary energy balance manipulations; 3) Examine mechanisms underlying the effects of CR on skin tumor promotion; and 4) Characterize the preventive effects of rapamycin (a selective inhibitor of mTOR), API-2 (a selective Akt inhibitor) and NVP-AE451 (a selective inhibitor of the IGF-1 receptor) on skin tumor promotion in ad libitum-fed or CR mice. The successful establishment of a causal link between the anticancer effects of CR and the IGF- 1R/Akt/mTOR pathway in epithelial carcinogenesis will provide a sound basis for translational studies to determine if targeting this pathway is a strategy for preventing epithelial cancers in humans.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fonc.2013.00209
发表时间:
2013
期刊:
Frontiers in oncology
影响因子:
4.7
作者:
[Ford NA, Lashinger LM, Allott EH, Hursting SD]
通讯作者:
Hursting SD
DOI:
10.1158/1940-6207.capr-14-0335
发表时间:
2015-10
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
[Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD]
通讯作者:
Hursting SD
DOI:
10.1158/1940-6207.capr-13-0110
发表时间:
2014-01
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
[Checkley LA, Rho O, Angel JM, Cho J, Blando J, Beltran L, Hursting SD, DiGiovanni J]
通讯作者:
DiGiovanni J
Minireview: the year in obesity and cancer.
小评论:肥胖和癌症的一年。
DOI:
10.1210/me.2012-1283
发表时间:
2012
期刊:
Molecular endocrinology (Baltimore, Md.)
影响因子:
--
作者:
[Hursting,StephenD]
通讯作者:
Hursting,StephenD
Impact of hypoxia on lipid metabolism in obesity-driven breast cancer progression
-
批准号:10604919
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2022
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10229282
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10683262
-
项目类别:
-
资助金额:$62.75万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10493126
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10381300
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10548139
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10524122
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10319580
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:9759569
-
项目类别:
-
资助金额:$47.25万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10079476
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:8956135
-
项目类别:
-
资助金额:$76.26万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:9117547
-
项目类别:
-
资助金额:$76.26万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:9764294
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8223255
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:7655953
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8027757
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:7821406
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10170771
-
项目类别:
-
资助金额:$15.55万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10601026
-
项目类别:
-
资助金额:$14.71万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10373074
-
项目类别:
-
资助金额:$14.95万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
海外基金